Rhenman & Partners Asset Management AB as of Sept. 30, 2019
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 93 positions in its portfolio as reported in the September 2019 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) | 4.0 | $32M | 186k | 169.42 | |
Horizon Therapeutics | 3.5 | $28M | 1.0M | 27.23 | |
Novocure Ltd ord (NVCR) | 3.2 | $25M | 340k | 74.78 | |
Alexion Pharmaceuticals | 3.0 | $24M | 247k | 97.94 | |
Esperion Therapeutics (ESPR) | 3.0 | $24M | 656k | 36.66 | |
Nektar Therapeutics (NKTR) | 2.7 | $22M | 1.2M | 18.22 | |
Abiomed | 2.7 | $21M | 120k | 177.89 | |
Bristol Myers Squibb (BMY) | 2.6 | $21M | 415k | 50.71 | |
Medtronic (MDT) | 2.5 | $20M | 185k | 108.62 | |
BioMarin Pharmaceutical (BMRN) | 2.5 | $20M | 291k | 67.40 | |
Jazz Pharmaceuticals (JAZZ) | 2.4 | $19M | 150k | 128.14 | |
CVS Caremark Corporation (CVS) | 2.4 | $19M | 304k | 63.07 | |
Abbott Laboratories (ABT) | 2.3 | $18M | 220k | 83.67 | |
Merck & Co (MRK) | 2.3 | $18M | 215k | 84.18 | |
Eli Lilly & Co. (LLY) | 2.1 | $17M | 150k | 111.83 | |
UnitedHealth (UNH) | 2.1 | $17M | 77k | 217.32 | |
Becton, Dickinson and (BDX) | 2.0 | $16M | 63k | 252.95 | |
Humana (HUM) | 1.9 | $15M | 60k | 255.67 | |
Boston Scientific Corporation (BSX) | 1.9 | $15M | 370k | 40.69 | |
Anthem (ELV) | 1.8 | $14M | 60k | 240.10 | |
Glaukos (GKOS) | 1.8 | $14M | 230k | 62.51 | |
Neurocrine Biosciences (NBIX) | 1.7 | $14M | 150k | 90.11 | |
Abbvie (ABBV) | 1.6 | $13M | 170k | 75.72 | |
Seattle Genetics | 1.6 | $13M | 149k | 85.40 | |
Regeneron Pharmaceuticals (REGN) | 1.6 | $13M | 45k | 277.41 | |
G1 Therapeutics | 1.5 | $12M | 536k | 22.78 | |
Cigna Corp (CI) | 1.5 | $12M | 80k | 151.79 | |
Immunomedics | 1.4 | $11M | 850k | 13.26 | |
Thermo Fisher Scientific (TMO) | 1.4 | $11M | 38k | 291.26 | |
Fibrogen (FGEN) | 1.4 | $11M | 295k | 36.98 | |
Myokardia | 1.3 | $10M | 200k | 52.15 | |
Macrogenics (MGNX) | 1.3 | $10M | 799k | 12.76 | |
Xencor (XNCR) | 1.3 | $10M | 303k | 33.73 | |
EXACT Sciences Corporation (EXAS) | 1.2 | $9.7M | 108k | 90.37 | |
Iovance Biotherapeutics (IOVA) | 1.2 | $9.5M | 520k | 18.20 | |
Aerie Pharmaceuticals | 1.1 | $9.1M | 475k | 19.22 | |
Hca Holdings (HCA) | 1.1 | $9.0M | 75k | 120.43 | |
Livanova Plc Ord (LIVN) | 1.1 | $8.9M | 120k | 73.79 | |
AmerisourceBergen (COR) | 1.0 | $8.2M | 99k | 82.33 | |
Edwards Lifesciences (EW) | 1.0 | $8.0M | 37k | 219.90 | |
Agios Pharmaceuticals (AGIO) | 1.0 | $7.9M | 245k | 32.40 | |
Mirati Therapeutics | 1.0 | $7.8M | 100k | 77.91 | |
Medicines Company | 1.0 | $7.7M | 153k | 50.00 | |
Centene Corporation (CNC) | 0.9 | $7.6M | 175k | 43.26 | |
Arena Pharmaceuticals | 0.9 | $7.1M | 155k | 45.77 | |
Sangamo Biosciences (SGMO) | 0.8 | $6.7M | 735k | 9.05 | |
Omnicell (OMCL) | 0.8 | $6.5M | 90k | 72.27 | |
Intra Cellular Therapies (ITCI) | 0.8 | $6.3M | 850k | 7.47 | |
Amarin Corporation (AMRN) | 0.8 | $6.1M | 400k | 15.16 | |
Coherus Biosciences (CHRS) | 0.7 | $5.9M | 290k | 20.26 | |
Incyte Corp. note 1.250 11/1 | 0.7 | $5.9M | 80k | 74.22 | |
Ra Pharmaceuticals | 0.7 | $5.8M | 244k | 23.65 | |
Exelixis (EXEL) | 0.7 | $5.7M | 320k | 17.68 | |
Alnylam Pharmaceuticals (ALNY) | 0.7 | $5.5M | 69k | 80.42 | |
D Stemline Therapeutics | 0.7 | $5.3M | 511k | 10.41 | |
Diplomat Pharmacy | 0.7 | $5.2M | 1.1M | 4.90 | |
Bluebird Bio (BLUE) | 0.6 | $4.8M | 52k | 91.83 | |
Epizyme | 0.6 | $4.6M | 450k | 10.31 | |
Dynavax Technologies (DVAX) | 0.6 | $4.4M | 1.2M | 3.58 | |
Alkermes (ALKS) | 0.5 | $4.3M | 220k | 19.51 | |
Silk Road Medical Inc Common | 0.5 | $4.1M | 125k | 32.53 | |
Radius Health | 0.5 | $3.9M | 150k | 25.75 | |
Rigel Pharmaceuticals | 0.5 | $3.7M | 2.0M | 1.87 | |
Dermira | 0.4 | $3.5M | 549k | 6.39 | |
HMS Holdings | 0.4 | $3.4M | 98k | 34.47 | |
Intercept Pharmaceuticals In | 0.4 | $3.2M | 48k | 66.37 | |
Aimmune Therapeutics | 0.4 | $3.1M | 149k | 20.94 | |
Nanostring Technologies (NSTGQ) | 0.4 | $3.1M | 142k | 21.59 | |
Acceleron Pharma | 0.3 | $2.8M | 70k | 39.51 | |
Sage Therapeutics (SAGE) | 0.3 | $2.8M | 20k | 140.30 | |
Madrigal Pharmaceuticals (MDGL) | 0.3 | $2.6M | 30k | 86.23 | |
Revance Therapeutics (RVNC) | 0.3 | $2.3M | 174k | 13.00 | |
Abeona Therapeutics | 0.3 | $2.3M | 1.0M | 2.26 | |
Guardant Health (GH) | 0.3 | $2.2M | 35k | 63.83 | |
Viewray (VRAYQ) | 0.2 | $1.8M | 635k | 2.90 | |
ArQule | 0.2 | $1.4M | 200k | 7.17 | |
Viking Therapeutics (VKTX) | 0.2 | $1.4M | 200k | 6.88 | |
Achillion Pharmaceuticals | 0.1 | $1.0M | 278k | 3.60 | |
Pieris Pharmaceuticals | 0.1 | $1.0M | 300k | 3.41 | |
Adverum Biotechnologies | 0.1 | $652k | 120k | 5.45 | |
JPMorgan Chase & Co. (JPM) | 0.0 | $291k | 2.5k | 117.72 | |
Chevron Corporation (CVX) | 0.0 | $353k | 3.0k | 118.70 | |
International Business Machines (IBM) | 0.0 | $322k | 2.2k | 145.37 | |
Anheuser-Busch InBev NV (BUD) | 0.0 | $324k | 3.4k | 95.04 | |
Microsoft Corporation (MSFT) | 0.0 | $213k | 1.5k | 139.03 | |
Exxon Mobil Corporation (XOM) | 0.0 | $272k | 3.9k | 70.58 | |
Walt Disney Company (DIS) | 0.0 | $271k | 2.1k | 130.10 | |
Wells Fargo & Company (WFC) | 0.0 | $266k | 5.3k | 50.46 | |
Symantec Corporation | 0.0 | $207k | 8.8k | 23.63 | |
Qualcomm (QCOM) | 0.0 | $259k | 3.4k | 76.38 | |
Ford Motor Company (F) | 0.0 | $267k | 29k | 9.16 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $272k | 377k | 0.72 | |
Janus Henderson Group Plc Ord (JHG) | 0.0 | $239k | 11k | 22.45 |